相关实验视频
Updated: May 5, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
针对衰老的肝细胞治疗与代谢功能障碍相关的脂肪性肝病和多器官功能障碍
Kuo Du1, David S Umbaugh2, Liuyang Wang3
1Department of Medicine, Duke University, Durham, NC, USA. kuo.du@duke.edu.
Nature communications
|March 29, 2025
概括
研究人员确定了一种衰老的肝细胞基因特征 (SHGS),可以追踪代谢功能障碍相关的脂肪性肝病 (MASLD) 的进展. 针对SHGS+肝细胞的老化剂在小鼠中改善了MASLD,这表明了一种新的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 细胞衰老 细胞衰老
- 代谢疾病 代谢疾病
背景情况:
- 衰老的肝细胞积聚在与代谢功能障碍相关的脂肪性肝病 (MASLD) 中,与不良的临床结果相关.
- 衰老肝细胞的异质性和缺乏特定标记物阻碍了治疗向.
研究的目的:
- 定义一个衰老的肝细胞基因签名 (SHGS) 来追踪MASLD.
- 调查MASLD中SHGS+肝细胞的起源,功能和治疗向.
主要方法:
- 在体外和体外模型,单核RNA测序和人类队列分析被用来定义SHGS.
- 功能性研究评估了SHGS+肝细胞在肝功能和疾病进展中的作用.
- 化学查发现了针对SHGS+肝细胞的老化剂.
主要成果:
- 在小鼠模型和人类队伍中,SHGS准确地追踪了MASLD的进展和回归.
- SHGS+肝细胞来源于p21+细胞,表现出肝功能受损,并分泌疾病促进因子,如GDF15.
- 在雄性小鼠中,通过老化剂向消除SHGS+肝细胞改善了MASLD.
- SHGS的丰富性也与其他器官的功能障碍相关.
结论:
- SHGS+肝细胞是MASLD的关键驱动因素.
- 向SHGS+衰老性肝细胞代表了对MASLD和其他潜在的肝脏疾病的潜在治疗策略.
- SHGS可以作为MASLD进展和治疗反应的生物标志物.
相关概念视频
Liver Regeneration
4.1K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42

